The 2 analysts offering 12-month price forecasts for First Wave BioPharma Inc have a median target of 10.50, with a high estimate of 11.00 and a low estimate of 10.00. The median estimate represents a +3,470.21% increase from the last price of 0.29.
The current consensus among 2 polled investment analysts is to Buy stock in First Wave BioPharma Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.86
Reporting Date Nov 13
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.